Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F McDermott

Showing results (421-430 of 567) with videos related to

Pageof 57
Sort By:
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|October 1, 1996
No linkage or association of telomeric and centromeric T-cell receptor beta-chain markers with susceptibility to type 1 insulin-dependent diabetes in HLA-DR4 multiplex familiesM F McDermott, G Schmidt-Wolf, A A Sinha, et al.
Journal for Immunotherapy of Cancer|March 19, 2022
Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinomaRobert J Motzer, Toni K Choueiri, David F McDermott, et al.
Applied and Environmental Microbiology|August 4, 2009
Antimicrobial resistance-conferring plasmids with similarity to virulence plasmids from avian pathogenic Escherichia coli strains in Salmonella enterica serovar Kentucky isolates from poultryW Florian Fricke, Patrick F McDermott, Mark K Mammel, et al.
The Lancet. Oncology|January 5, 2025
Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma (LITESPARK-003): an open-label, single-arm, phase 2 studyToni K Choueiri, Jaime R Merchan, Robert Figlin, et al.
Genes and Immunity|February 22, 2002
Genetic susceptibility to fibrocalculous pancreatic diabetes in Bangladeshi subjects: a family studyZ Md Chowdhury, M F McDermott, S Davey, et al.
Annals of the Rheumatic Diseases|June 9, 2012
Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndromeLaura J Dickie, Azad M Aziz, Sinisa Savic, et al.
Psychological Assessment|July 11, 2000
Psychometric properties of the Hawaiian Culture Scale--Adolescent VersionE S Hishinuma, N N Andrade, R C Johnson, et al.
Genes and Immunity|April 9, 2004
Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosisE Aganna, P N Hawkins, S Ozen, et al.
Annals of the Rheumatic Diseases|December 19, 2007
A novel TNFRSF1A splice mutation associated with increased nuclear factor kappaB (NF-kappaB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS)S M Churchman, L D Church, S Savic, et al.
Journal for Immunotherapy of Cancer|November 20, 2021
Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067Meredith M Regan, Charlene M Mantia, Lillian Werner, et al.
Pageof 57

Showing results (421-430 of 567) with videos related to

Sort By:
Pageof 57
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|October 1, 1996
No linkage or association of telomeric and centromeric T-cell receptor beta-chain markers with susceptibility to type 1 insulin-dependent diabetes in HLA-DR4 multiplex familiesM F McDermott, G Schmidt-Wolf, A A Sinha, et al.
Journal for Immunotherapy of Cancer|March 19, 2022
Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinomaRobert J Motzer, Toni K Choueiri, David F McDermott, et al.
Applied and Environmental Microbiology|August 4, 2009
Antimicrobial resistance-conferring plasmids with similarity to virulence plasmids from avian pathogenic Escherichia coli strains in Salmonella enterica serovar Kentucky isolates from poultryW Florian Fricke, Patrick F McDermott, Mark K Mammel, et al.
The Lancet. Oncology|January 5, 2025
Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma (LITESPARK-003): an open-label, single-arm, phase 2 studyToni K Choueiri, Jaime R Merchan, Robert Figlin, et al.
Genes and Immunity|February 22, 2002
Genetic susceptibility to fibrocalculous pancreatic diabetes in Bangladeshi subjects: a family studyZ Md Chowdhury, M F McDermott, S Davey, et al.
Annals of the Rheumatic Diseases|June 9, 2012
Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndromeLaura J Dickie, Azad M Aziz, Sinisa Savic, et al.
Psychological Assessment|July 11, 2000
Psychometric properties of the Hawaiian Culture Scale--Adolescent VersionE S Hishinuma, N N Andrade, R C Johnson, et al.
Genes and Immunity|April 9, 2004
Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosisE Aganna, P N Hawkins, S Ozen, et al.
Annals of the Rheumatic Diseases|December 19, 2007
A novel TNFRSF1A splice mutation associated with increased nuclear factor kappaB (NF-kappaB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS)S M Churchman, L D Church, S Savic, et al.
Journal for Immunotherapy of Cancer|November 20, 2021
Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067Meredith M Regan, Charlene M Mantia, Lillian Werner, et al.
Pageof 57